Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma

Giovanni Riva,Ivana Lagreca,Adriana Mattiolo,Daniela Belletti,Laura Lignitto,Patrizia Barozzi,Barbara Ruozi,Daniela Vallerini,Chiara Quadrelli,Giorgia Corradini,Fabio Forghieri,Roberto Marasca,Franco Narni,Giovanni Tosi,Flavio Forni,Maria Angela Vandelli,Alberto Amadori,Luigi Chieco-Bianchi,Leonardo Potenza,Maria Luisa Calabrò,Mario Luppi

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma

2015

RNA interference (RNAi) has been suggested to represent a promising therapeutic approach in different disease settings. Primary effusion lymphoma (PEL) is a plasmablastic lymphoma consistently expressing B lymphocyte-induced maturation protein 1 (Blimp-1), a pivotal transcriptional regulator during

Keywords:

Primary effusion lymphoma
Immunology
RNA interference
Liposome
Hematology
Small interfering RNA
Virology
Plasmablastic lymphoma
Cancer research
PRDM1
Biology
Transcriptional regulation
Internal medicine
Repressor
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations